Allelic polymorphism -491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment (Q44024429)

29 November 2017

title

Allelic polymorphism -491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment (English)

1 reference

29 November 2017

1 reference

1 reference

A-L García-Otín

1

1 reference

29 November 2017

F Civeira

2

1 reference

29 November 2017

R Aristegui

3

1 reference

29 November 2017

C Díaz

4

1 reference

29 November 2017

D Recalde

5

1 reference

29 November 2017

J M Sol

6

1 reference

29 November 2017

X Masramon

7

1 reference

29 November 2017

G Hernández

8

1 reference

29 November 2017

M Pocoví

9

1 reference

29 November 2017

ATOMIX Study Group. Atorvastatin in Mixed dyslipidemia

10

1 reference

29 November 2017

publication date

1 June 2002

1 reference

European Journal of Clinical Investigation

29 November 2017

published in

1 reference

29 November 2017

volume

32

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

421-428

1 reference

Combined hyperlipidemia as a risk factor for premature atherosclerotic disease

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Defects of lipoprotein metabolism in familial combined hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Novel genes for familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Familial lipoprotein disorders in patients with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Effects of statins on triglyceride metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus Relationships with lipids, apolipoproteins, and premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00996.X

10.1046/J.1365-2362.2002.00996.X

21 January 2018

Identifiers

DOI

1 reference

release_k6cd3rgfhndehhzxljh25hixwm

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k6cd3rgfhndehhzxljh25hixwm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference